Literature DB >> 29570507

How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study.

Simon Haroutounian1,2, Andria L Ford3, Karen Frey1, Lone Nikolajsen4,5, Nanna B Finnerup4,6, Alicia Neiner1, Evan D Kharasch2,7, Pall Karlsson4, Michael M Bottros1,2.   

Abstract

Central poststroke pain (CPSP) is a neuropathic pain disorder, the underlying mechanisms of which are not well understood. It has been suggested that stroke-associated loss of inhibitory neurons in the spinothalamic tract causes disinhibition of thalamic neurons, which autonomously generate ectopic nociceptive action potentials responsible for the pain experience. We hypothesized that CPSP is a result of misinterpretation of afferent sensory input by the sensitized neurons within the brain, rather than generated spontaneously by the damaged central nervous system (CNS) neurons. To test this hypothesis, we prospectively recruited 8 patients with definite CPSP affecting at least 1 extremity. In an open-label intervention, an ultrasound-guided peripheral nerve block with lidocaine was performed to block afferent sensory input from a painful extremity. Spontaneous and evoked pain, neuropathic pain descriptors, and lidocaine plasma concentrations were measured. The blockade of peripheral sensory input resulted in complete abolition of pain in 7 of the 8 subjects within 30 minutes (the primary outcome measure of the study), and >50% pain relief in the remaining participant. Median (interquartile range) spontaneous pain intensity changed from 6.5 (4.3-7.0) at baseline to 0 (0-0) after the block (P = 0.008). All mechanical/thermal hypersensitivity was abolished by the nerve block. The results suggest that it is unlikely that CPSP is autonomously generated within the CNS. Rather, this pain is dependent on afferent input from the painful region in the periphery, and may be mediated by misinterpretation of peripheral sensory input by sensitized neurons in the CNS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29570507     DOI: 10.1097/j.pain.0000000000001213

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

1.  Recent advances toward understanding the mysteries of the acute to chronic pain transition.

Authors:  Theodore J Price; Pradipta R Ray
Journal:  Curr Opin Physiol       Date:  2019-06-04

Review 2.  Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Authors:  Katharine N Gurba; Rida Chaudhry; Simon Haroutounian
Journal:  CNS Drugs       Date:  2022-05-05       Impact factor: 6.497

3.  Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain.

Authors:  Salim Megat; Pradipta R Ray; Jamie K Moy; Tzu-Fang Lou; Paulino Barragán-Iglesias; Yan Li; Grishma Pradhan; Andi Wanghzou; Ayesha Ahmad; Michael D Burton; Robert Y North; Patrick M Dougherty; Arkady Khoutorsky; Nahum Sonenberg; Kevin R Webster; Gregory Dussor; Zachary T Campbell; Theodore J Price
Journal:  J Neurosci       Date:  2018-11-20       Impact factor: 6.167

Review 4.  Pharmacotherapy to Manage Central Post-Stroke Pain.

Authors:  Hanwool Ryan Choi; Adem Aktas; Michael M Bottros
Journal:  CNS Drugs       Date:  2021-02-07       Impact factor: 5.749

5.  Tweety-Homolog 1 Facilitates Pain via Enhancement of Nociceptor Excitability and Spinal Synaptic Transmission.

Authors:  Wen-Juan Han; Sui-Bin Ma; Wen-Bin Wu; Fu-Dong Wang; Xiu-Li Cao; Dong-Hao Wang; Hai-Ning Wu; Rou-Gang Xie; Zhen-Zhen Li; Fei Wang; Sheng-Xi Wu; Min-Hua Zheng; Ceng Luo; Hua Han
Journal:  Neurosci Bull       Date:  2020-12-23       Impact factor: 5.203

6.  Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief.

Authors:  Tzer-Bin Lin; Hsien-Yu Peng; Ming-Chun Hsieh; Yu-Cheng Ho; Cheng-Yuan Lai; Hsueh-Hsiao Wang; Po-Sheng Yang; Jen-Kun Cheng; Gin-Den Chen; Soo-Cheen Ng; An-Sheng Lee; Kuang-Wen Tseng
Journal:  Neurotherapeutics       Date:  2021-01-07       Impact factor: 7.620

7.  Assessment of neuropathic pain after spinal cord injury using quantitative pain drawings.

Authors:  Jan Rosner; Robin Lütolf; Pascal Hostettler; Michael Villiger; Ron Clijsen; Erich Hohenauer; Marco Barbero; Armin Curt; Michèle Hubli
Journal:  Spinal Cord       Date:  2021-02-16       Impact factor: 2.772

Review 8.  Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety.

Authors:  Martin Schmelz; Patrick Mantyh; Anne-Marie Malfait; John Farrar; Tony Yaksh; Leslie Tive; Lars Viktrup
Journal:  Pain       Date:  2019-10       Impact factor: 7.926

Review 9.  Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain.

Authors:  Muhammad Saad Yousuf; Stephanie I Shiers; James J Sahn; Theodore J Price
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

10.  John J. Bonica Award Lecture: Peripheral neuronal hyperexcitability: the "low-hanging" target for safe therapeutic strategies in neuropathic pain.

Authors:  Srinivasa N Raja; Matthias Ringkamp; Yun Guan; James N Campbell
Journal:  Pain       Date:  2020-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.